EpiBone is a biomedical engineering company that is developing technology to create bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts.
EpiBone is on a mission to use groundbreaking research to transform skeletal repair. Sitting at the intersection of biology and engineering, the company harnesses the power of a patient's own cells to create living solutions that become a seamless part of a patient's body. EpiBone is currently developing a pipeline of bone, cartilage, and compound (bone and cartilage) products. Its product named EB-CMF is a living anatomically correct bone graft manufactured from a patient's own adipose derived stem cells. This eliminates the need to harvest bone from a patient's body, potentially reducing pain, surgical and hospitalisation time while creating a precision fit with the defect.